Correlation Between Prestige Biologics and FNSTech

Can any of the company-specific risk be diversified away by investing in both Prestige Biologics and FNSTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prestige Biologics and FNSTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Prestige Biologics Co and FNSTech Co, you can compare the effects of market volatilities on Prestige Biologics and FNSTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prestige Biologics with a short position of FNSTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prestige Biologics and FNSTech.

Diversification Opportunities for Prestige Biologics and FNSTech

0.37

Correlation Coefficient

Prestige Biologics  FNSTech

Weak diversification

The 3 months correlation between Prestige and FNSTech is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Prestige Biologics Co and FNSTech Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FNSTech and Prestige Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prestige Biologics Co are associated (or correlated) with FNSTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FNSTech has no effect on the direction of Prestige Biologics i.e., Prestige Biologics and FNSTech go up and down completely randomly.

Pair Corralation between Prestige Biologics and FNSTech

Assuming the 90 days trading horizon Prestige Biologics Co is expected to under-perform the FNSTech. But the stock apears to be less risky and, when comparing its historical volatility, Prestige Biologics Co is 1.06 times less risky than FNSTech. The stock trades about -0.16 of its potential returns per unit of risk. The FNSTech Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  973,000  in FNSTech Co on October 23, 2024 and sell it today you would earn a total of  66,000  from holding FNSTech Co or generate 6.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Prestige Biologics Co  vs.  FNSTech Co

Prestige Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prestige Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

FNSTech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in FNSTech Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, FNSTech may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Prestige Biologics and FNSTech

The main advantage of trading using opposite Prestige Biologics and FNSTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prestige Biologics position performs unexpectedly, FNSTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FNSTech will offset losses from the drop in FNSTech's long position.

The idea behind Prestige Biologics Co and FNSTech Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.